semaglutide and als Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report Do Sodium-Glucose Cotransporter-2 Inhibitors Influence

In conclusion, GLP-1 RAs are an intriguing multitarget treatment option for people with NDs, and future research should focus on optimizing treatment for clinical trials, evolved agonists that can penetrate the central nervous system (CNS), and combination therapies.

Due to the bodys natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.

Hiccups typically arent serious, but they can be hard to shake

GLP-1 RAs in combination with metformin showed even more weight loss and improvement in markers of hyperandrogenism

and electrolytes, leaving you feeling fatigued, lightheaded, or depleted

GLP-1